CSF-1R as an inhibitor of apoptosis and promoter of proliferation, migration and invasion of canine mammary cancer cells

BMC Veterinary Research

Volumn 9, Issue , 2013, Pages

  Król, Magdalena ^a   Majchrzak, Kinga ^a   Mucha, Joanna ^a   Homa, Agata ^a   Bulkowska, Małgorzata ^a   Jakubowska, Arleta ^a   Karwicka, Malwina ^a   Pawłowski, Karol M ^a   Motyl, Tomasz ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Canine mammary carcinoma; CSF 1R; Tumor microenvironment; Tumor associated macrophages

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR;

ANIMAL; ANIMAL DISEASE; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; DOG; DOG DISEASE; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; FLOW CYTOMETRY; METASTASIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING; VETERINARY;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 84875832542     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-9-65     Document Type: Article

References (26)

1. Richardsen E, Sorbye SW, Crowe JP, Yang JL, Busund LT. Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors. Anticancer Res 2009, 29:3861-3866.
2. Lin EY, Pollard JW. Role of infiltrated leucocytes in tumor growth and spread. Br J Cancer 2004, 90:20-53-2058.
3. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
4. Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. J Leukocyte Biol 1998, 64:275-288.
5. Priceman SJ, Sung JL, Shaposhnik Z, Burton JB, Torres-Collado AX, Moughon DL, Johnson M, Lusis AJ, Cohen DA, Iruela-Aripse ML, Wu L. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 2010, 115:1461-1471. 10.1182/blood-2009-08-237412, 2826767, 20008303.
6. Morandi A, Barbetti V, Riverso M, Sbarba PD, Rovida E. The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in Brest cancer cell lines. PLoS One 2011, 6(1):e27450. 10.1371/journal.pone.0027450, 3212567, 22096574.
7. Sapi E. The role of CSF-1 in normal physiology of mammary gland and breast cancer: an update. Exp Biol Med 2004, 229:1-11.
8. Król M, Pawłowski KM, Majchrzak K, Gajewska M, Majewska A, Motyl T. Global gene expression profiles of canine macrophages and canine mammary cancer cells grown as a co-culture in vitro. BMC Vet Res 2012, 8:16. 10.1186/1746-6148-8-16, 3315417, 22353646.
9. Patsialou A, Wyckoff J, Wang Y, Goswami S, Stanley ER, Condeelis JS. Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony stimulating factor-1 receptor. Cancer Res 2009, 69:9498-9506. 10.1158/0008-5472.CAN-09-1868, 2794986, 19934330.
10. Król M, Pawłowski KM, Majchrzak K, Dolka I, Abramowicz A, Szyszko K, Motyl T. Density of tumor-associated macrophages (TAMs) and expression of their growth factor receptor MCSF-R and CD14 in canine mammary adenocarcinomas of various grade of malignancy and metastasis. Pol J Vet Sci 2011, 14:3-10.
11. Król M, Pawłowski KM, Skierski J, Rao NAS, Hellmen E, Mol JA, Motyl T. Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential. J Physiol Pharmacol 2009, 60:95-106.
12. Król M, Pawłowski KM, Skierski J, Turowski P, Majewska A, Polańska J, Ugorski M, Morty RE, Motyl T. Transcriptomic " portraits" of canine mammary cancer cell lines with various phenotype. J Appl Genet 2010, 51:169-183. 10.1007/BF03195725, 20453304.
13. Król M, Polańska J, Pawłowski KM, Skierski J, Majewska A, Ugorski M, Motyl T. Molecular signature of cell lines isolated from mammary adenocarcinoma metastases to lungs. J Appl Genet 2010, 51:37-50. 10.1007/BF03195709, 20145299.
14. Pawłowski KM, Popielarz D, Szyszko K, Motyl T, Król M. Growth Hormone Receptor RNA interference decreases proliferation and enhances apoptosis in canine mammary carcinoma cell line CMT-U27. Vet Comp Oncol 2012, 10(1):2-15. 10.1111/j.1476-5829.2011.00269.x, 22235976.
15. Schmittgen TD, Livac KJ. Analyzing real-time PCR data by the comparative Ct method. Nat Prot 2008, 3:1101-1108.
16. Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, Francis GD, Herington AC, Chopin LK. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer 2005, 12:839-850. 10.1677/erc.1.00984, 16322325.
17. Lee AW, Nambirajan S, Moffat JG. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells. Oncogene 1999, 18:7477-7494. 10.1038/sj.onc.1203123, 10602507.
18. Sokolowski JH. False pregnancy. Vet Clin North Am 1982, 12:93-98.
19. Gobello C, Concannon PW, Verstegen J. Canine pseudopregnancy: A Review. Recent advances in Small animal reproduction 2011, Ithaca, New York USA Retrieved: International Veterinary Information Services, Concannon PW, England G, Verstegen J, (www.ivis.org).
20. Wittrant Y, Gorin Y, Mohan S, Wagner B, Abboud-Werner SL. Colony-stimulating factor-1 (CSF-1) directly inhibits receptor activator of nuclear factor-kB ligand (RANKL) expression by osteoblasts. Endocrinology 2009, 150:4977-4988. 10.1210/en.2009-0248, 2775986, 19819976.
21. Chen G, Gharib TG, Huang CC, Taylor JMG, Misek DE, Kardia SLR, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Discordant protein and mRNA expression in lung adenocarcinomas. Mol and Cel Proteom 2002, 1.4:304-313.
22. Pascal LE, True LD, Campbell DS, Deutsch EW, Risk M, Coleman IM, Eichner LJ, Nelson PS, Liu AY. Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 2008, 9:246. 10.1186/1471-2164-9-246, 2413246, 18501003.
23. Ullrich K, Wurster KD, Lamprecht B, Kochert K, Engert A, Dorken B, Janz M, Mathas S. BAY 43-9005/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines. Brit J Haemat 2011, 155:395-408. 10.1111/j.1365-2141.2011.08682.x, 21554257.
24. Roussel MF. Regulation of cell cycle entry and G1 progression by CSF-1. Mol Reprod Dev 1997, 46:11-18. 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U, 8981358.
25. Sapi E, Flick MB, Rodov S, Gilmore-Hebert M, Kelley M, Rockwell S, Kacinski BM. Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor. Cancer Res 1996, 56:5704-5712.
26. Hume DA, MacDonald PA. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2011, 119:1810-1820.